Robert Henry Perry
#152,209
Most Influential Person Across History
Robert Henry Perry's AcademicInfluence.com Rankings
Download Badge
Philosophy Biology
Robert Henry Perry's Degrees
- Doctorate Medicine Harvard University
- PhD Neuroscience Stanford University
Why Is Robert Henry Perry Influential?
(Suggest an Edit or Addition)Robert Henry Perry's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Diagnosis and management of dementia with Lewy bodies (2005) (3346)
- Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. (1996) (2280)
- Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) (1996) (2138)
- Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. (1978) (2024)
- High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease (2006) (1394)
- NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA (1977) (933)
- A harmonized classification system for FTLD-TDP pathology (2011) (781)
- Neurotransmitter enzyme abnormalities in senile dementia Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue (1977) (721)
- Neuroleptic sensitivity in patients with senile dementia of Lewy body type. (1992) (641)
- Senile dementia of Lewy body type A clinically and neuropathologically distinct form of Lewy body dementia in the elderly (1990) (594)
- Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. (1985) (571)
- D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. (1997) (546)
- CHANGES IN BRAIN CHOLINESTERASES IN SENILE DEMENTIA OF ALZHEIMER TYPE (1978) (500)
- Report of the second dementia with Lewy body international workshop (1999) (484)
- Pathological changes in the nucleus of meynert in Alzheimer's and Parkinson's diseases (1983) (456)
- Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies (2000) (451)
- Operational criteria for senile dementia of Lewy body type (SDLT) (1992) (429)
- ALUMINOSILICATES AND SENILE PLAQUE FORMATION IN ALZHEIMER'S DISEASE (1986) (429)
- White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging (1999) (412)
- Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: Possible index of early neuropathology (1995) (391)
- Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study. (2002) (370)
- Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. (2001) (347)
- Neuropathology of dementia in Parkinson's disease: A prospective, community‐based study (2005) (335)
- Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. (1999) (326)
- Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype (2006) (309)
- Differences in neuropathologic characteristics across the Lewy body dementia spectrum (2006) (308)
- Neurotransmitter receptors and monoamine metabolites in the brains of patients with Alzheimer-type dementia and depression, and suicides (1984) (305)
- Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease. (1999) (304)
- Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma. (1997) (286)
- Acetylcholine and Hallucinations - Disease-Related Compared to Drug-Induced Alterations in Human Consciousness (1995) (283)
- Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy (2007) (282)
- Towards defining the neuropathological substrates of vascular dementia (2004) (275)
- Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease (1981) (260)
- Neuronal Nicotinic Receptors in Dementia with Lewy Bodies and Schizophrenia (1999) (257)
- The rate of cognitive decline in Parkinson disease. (2004) (256)
- Decreased Imipramine Binding in the Brains of Patients with Depressive Illness (1983) (254)
- Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of meynert in Alzheimer's disease (1982) (245)
- The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts (2007) (234)
- Coenzyme a-acetylating enzymes in Alzheimer's disease: Possible cholinergic ‘compartment’ of pyruvate dehydrogenase (1980) (233)
- Nicotinic receptor abnormalities in the cerebellar cortex in autism. (2002) (232)
- Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs (2003) (226)
- Anxiety, depression and psychosis in vascular dementia: prevalence and associations. (2000) (218)
- Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes (1981) (218)
- Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: Selective loss of the intermediate (10S) form (1983) (216)
- Cholinergic Transmitter and Neurotrophic Activities in Lewy Body Dementia: Similarity to Parkinson's and Distinction from Alzheimer Disease (1993) (212)
- Dementia with Lewy bodies. (2007) (212)
- Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer’s disease, and dementia with Lewy bodies (2010) (208)
- Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. (2000) (204)
- Evidence of a Monoaminergic‐Cholinergic Imbalance Related to Visual Hallucinations in Lewy Body Dementia (1990) (203)
- Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias. (2005) (197)
- α4 but Not α3 and α7 Nicotinic Acetylcholine Receptor Subunits Are Lost from the Temporal Cortex in Alzheimer's Disease (1999) (190)
- Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases. (1987) (181)
- Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD (2005) (179)
- Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia (2001) (179)
- Molecular Forms of Acetylcholinesterase and Butyrylcholinesterase in the Aged Human Central Nervous System (1986) (176)
- An evaluation of the predictive validity and inter‐rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type (1994) (174)
- Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease (1981) (174)
- A cholinergic connection between normal aging and senile dementia in the human hippocampus (1977) (172)
- Clinical and molecular stratification of disease risk in medulloblastoma (2001) (172)
- Convergent cholinergic activities in aging and Alzheimer's disease (1992) (170)
- Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson’s disease and Alzheimer’s disease and in relation to neuroleptic medication (2000) (163)
- Delusions associated with elevated muscarinic binding in dementia with Lewy bodies (2000) (160)
- Topography, Extent, and Clinical Relevance of Neurochemical Deficits in Dementia of Lewy Body Type, Parkinson's Disease, and Alzheimer's Disease (1991) (157)
- Endogenous neurogenesis in the human brain following cerebral infarction. (2007) (156)
- Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology (2012) (154)
- Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging. (1997) (151)
- Altered neurogenesis in Alzheimer's disease. (2006) (151)
- EEG findings in dementia with Lewy bodies and Alzheimer’s disease (1999) (151)
- Monoamine metabolism in senile dementia of Alzheimer type (1983) (151)
- Genetic abnormalities detected in ependymomas by comparative genomic hybridisation (2002) (149)
- Nicotinic Acetylcholine Receptor Distribution in Alzheimer's Disease, Dementia with Lewy Bodies, Parkinson's Disease, and Vascular Dementia: In Vitro Binding Study Using 5-[125I]-A-85380 (2004) (149)
- Recent advances in neuropathology. (1986) (147)
- Cholinergic Receptors in Cognitive Disorders (1986) (146)
- Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. (1994) (146)
- Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease (2004) (144)
- Molecular analysis of nicotinic receptor expression in autism. (2004) (143)
- Alzheimer's disease is associated with a selective increase in α7 nicotinic acetylcholine receptor immunoreactivity in astrocytes (2003) (143)
- Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use (1998) (138)
- Experimental stroke and neuroprotection in the aging rat brain. (1995) (138)
- Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types (1990) (132)
- Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies. (2004) (132)
- Pathologies and Pathological Mechanisms for White Matter Hyperintensities in Depression (2002) (130)
- 5-HT receptor binding in post-mortem brain from patients with affective disorder. (1987) (130)
- Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type (1984) (128)
- The influence of agonal status on some neurochemical activities of postmortem human brain tissue (1982) (124)
- Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation (2006) (123)
- Staging and natural history of cerebrovascular pathology in dementia (2012) (122)
- Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma. (1995) (119)
- Neuropeptides in Alzheimer's disease, depression and schizophrenia A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex (1981) (118)
- alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease. (2004) (118)
- Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients. (1992) (118)
- Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology. (2007) (116)
- Oxidative Damage to Proteins, Lipids, and DNA in Cortical Brain Regions from Patients with Dementia with Lewy Bodies (1998) (113)
- The Clinical Diagnosis and Misdiagnosis of Senile Dementia of Lewy Body Type (SDLT) (1994) (111)
- The most common type of FTLD-FUS (aFTLD-U) is associated with a distinct clinical form of frontotemporal dementia but is not related to mutations in the FUS gene (2011) (109)
- Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies (2000) (109)
- Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease. (1991) (109)
- Expression of the ErbB-neuregulin signaling network during human cerebellar development: implications for the biology of medulloblastoma. (1998) (108)
- Triphenyltetrazolium chloride (TTC) as a marker for ischaemic changes in rat brain following permanent middle cerebral artery occlusion (1991) (108)
- Neuropathological evidence for ischemia in the white matter of the dorsolateral prefrontal cortex in late‐life depression (2003) (106)
- CORTICAL CHOLINERGIC DEFICIT IN MENTALLY IMPAIRED PARKINSONIAN PATIENTS (1983) (106)
- Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia. (1994) (105)
- Histochemical observations on cholinesterase activities in the brains of elderly normal and demented (Alzheimer-type) patients. (1980) (105)
- Cholinergic and Dopaminergic Activities in Senile Dementia of Lewy Body Type (1990) (104)
- CLINICALLY AND NEUROPATHOLOGICALLY DISTINCT FORM OF DEMENTIA IN THE ELDERLY (1989) (104)
- Apolipoprotein E genes in Lewy body and Parkinson's disease (1994) (102)
- The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies (1997) (100)
- Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: Comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients (1991) (98)
- A neuropathological study of vascular factors in late-life depression (2001) (97)
- Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei (1990) (96)
- Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases (1991) (95)
- Intralaminar Neurochemical Distributions in Human Midtemporal Cortex: Comparison Between Alzheimer's Disease and the Normal (1984) (95)
- Human brain neurochemistry - some postmortem problems. (1983) (94)
- Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex. (2000) (94)
- Preferential deposition of amyloid β protein (Aβ) in the form Aβ 40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele (1997) (92)
- [3H]MK-801 binding to the NMDA receptor complex, and its modulation in human frontal cortex during development and aging (1992) (92)
- A neuropathological study of periventricular white matter hyperintensities in major depression. (2003) (89)
- Neuropathological Substrates of Dementia and Depression in Vascular Dementia, with a Particular Focus on Cases with Small Infarct Volumes (2000) (86)
- Metabolically Active Synaptosomes Can Be Prepared from Frozen Rat and Human Brain (1983) (85)
- The cholinergic system in Alzheimer's disease (1982) (83)
- Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions (2003) (82)
- Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein. (1994) (80)
- Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: Comparisons with Parkinson's disease (1984) (79)
- Clinical neurochemistry: developments in dementia research based on brain bank material (1998) (78)
- Nicotinic receptor distribution in the human thalamus: autoradiographical localization of [3H]nicotine and [125I]α-bungarotoxin binding (1997) (78)
- The Association between White Matter Lesions on Magnetic Resonance Imaging and Noncognitive Symptoms (2000) (77)
- Regional patterns of cholinergic and glutamate activity in the developing and aging human brain. (1993) (76)
- Postmortem Neurochemical Studies in Depression (1986) (76)
- Hippocampal Free Amino Acids in Alzheimer's Disease (1980) (75)
- ApoE genotype and Down's syndrome (1994) (74)
- Pathological correlates of frontotemporal lobar degeneration in the elderly (2011) (73)
- Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380. (2004) (73)
- Senile dementia of the Lewy body type has an apolipoprotein E ε4 allele frequency intermediate between controls and Alzheimer's disease (1994) (71)
- Apolipoprotein E ϵ4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls (1994) (71)
- Neuronal nicotinic acetylcholine receptor subunits in autism: an immunohistochemical investigation in the thalamus (2005) (71)
- Muscarinic Cholinergic Receptor Subtypes in Hippocampus in Human Cognitive Disorders (1988) (70)
- Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease (2003) (69)
- Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study (2002) (69)
- A Detailed Phenomenological Comparison of Complex Visual Hallucinations in Dementia With Lewy Bodies and Alzheimer's Disease (1997) (68)
- No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease. (1998) (65)
- Accumulation of dipeptide repeat proteins predates that of TDP‐43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene (2015) (65)
- Nigrostriatal dopaminergic activities in dementia with lewy bodies in relation to neuroleptic sensitivity: comparisons with parkinson’s disease (1998) (65)
- Clinical and Neuropathological Correlates of Apolipoprotein E Genotype in Dementia with Lewy Bodies (2002) (64)
- Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types (2000) (63)
- Monoaminergic activities in Lewy Body dementia: Relation to hallucinosis and extrapyramidal features (1993) (62)
- Guanine nucleotide modulation of muscarinic cholinergic receptor binding in postmortem human brain — A preliminary study in Alzheimer's disease (1987) (62)
- Single‐cell expression profiling of dopaminergic neurons combined with association analysis identifies pyridoxal kinase as Parkinson's disease gene (2009) (60)
- The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease. (1986) (60)
- Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease (1995) (58)
- Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. (1999) (56)
- Simple Standardised NeuropsychologicalAssessments Aid in the Differential Diagnosis of Dementia with Lewy Bodies from Alzheimer’s Disease and Vascular Dementia (1999) (56)
- Cerebral Cholinergic Activity Is Related to the Incidence of Visual Hallucinations in Senile Dementia of Lewy Body Type (1990) (55)
- Comparison of Extrapyramidal Signs in Dementia With Lewy Bodies and Parkinson's Disease (2001) (55)
- Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology (2004) (55)
- Recovery and measurement of specific RNA species from postmortem brain tissue: a general reduction in Alzheimer's disease detected by molecular hybridization. (1986) (55)
- Post mortem levels of thyrotropin-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression (1983) (54)
- Biochemical assay of Alzheimer's disease--associated protein(s) in human brain tissue. A clinical study. (1990) (53)
- Absence of cholinergic deficits in “pure” vascular dementia (2005) (53)
- Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease (1990) (52)
- Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies (2005) (52)
- Expression of the α3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease (1998) (52)
- α-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases (2004) (51)
- Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias. (1996) (50)
- Frontotemporal dementia in elderly individuals. (2012) (50)
- Autoradiographic distribution of [3H]nicotine binding in human cortex: Relative abundance in subicular complex (1992) (50)
- Detection of Lewy Bodies in Trisomy 21 (Down's Syndrome) (1993) (50)
- Solitary extranodal lymphoma of sciatic nerve (1986) (49)
- Sodium dependent d-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases (1987) (48)
- Magnetic resonance imaging differences between dementia with Lewy bodies and Alzheimer's disease: a pilot study (1999) (48)
- Synaptic Proteins and Choline Acetyltransferase Loss in Visual Cortex in Dementia With Lewy Bodies (2013) (47)
- PLASMA AND ERYTHROCYTE ACETYLCHOLINESTERASE IN SENILE DEMENTIA OF ALZHEIMER TYPE (1982) (47)
- Alpha and beta nicotinic acetylcholine receptors subunits and synaptophysin in putamen from Parkinson's disease (2000) (46)
- CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease. (1999) (46)
- Effects of apolipoprotein E genotype on cortical neuropathology in senile dementia of the Lewy body and Alzheimer's disease. (1995) (46)
- Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease. (2001) (46)
- Changes in benzodiazepine and acetylcholine receptors in the globus pallidus in Parkinson's disease (1990) (46)
- Molecular Forms of Acetylcholinesterase and Butyrylcholinesterase in Human Plasma and Cerebrospinal Fluid (1987) (46)
- Malignant choroid plexus papilloma with extraneural metastasis. Case report. (1980) (45)
- Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [125I]α-conotoxinMII in the striatum and thalamus (2005) (45)
- Evidence for the early prenatal development of cortical cholinergic afferents from the nucleus of Meynert in the human foetus (1985) (45)
- HLA‐DR antigens associated with major genetic risk for late‐onset Alzheimer's disease (1997) (45)
- A detailed anatomical analysis of neurotransmitter receptors in the putamen and caudate in Parkinson's disease and Alzheimer's disease (1994) (44)
- One Year Follow-Up of Parkinsonism in Dementia with Lewy Bodies (2000) (44)
- Neuropeptide localisation in the substantia innominata and adjacent regions of the human brain. (1985) (44)
- Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression (1990) (44)
- Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load (2015) (43)
- Neocortical Cholinergic Enzyme and Receptor Activities in the Human Fetal Brain (1986) (43)
- The substantia innominata and adjacent regions in the human brain: histochemical and biochemical observations. (1984) (43)
- Lack of association of the α2-macroglobulin locus on chromosome 12 in AD (2000) (43)
- Mitotic percentage index: a new prognostic factor for childhood medulloblastoma. (1997) (42)
- Distribution of corticotropin-releasing factor-like immunoreactivity in human brain (1987) (42)
- An autoradiographic analysis of serotonin receptors in human temporal cortex: Changes in Alzheimer-type dementia (1988) (42)
- Cognitive impairment in depression is not associated with neuropathologic evidence of increased vascular or Alzheimer-type pathology (2001) (41)
- Cortical Serotonin 1A Receptor Levels Are Associated with Depression in Patients with Dementia with Lewy Bodies and Parkinson’s Disease Dementia (2008) (40)
- p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis. (1993) (40)
- Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain. (1989) (40)
- Lewy body disease: Thalamic cholinergic activity related to dementia and parkinsonism (2006) (40)
- NORADRENERGIC AND CHOLINERGIC SYSTEMS IN SENILE DEMENTIA OF ALZHEIMER TYPE (1981) (39)
- Agonal status affects the metabolic activity of nerve endings isolated from postmortem human brain. (1985) (38)
- Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex (2002) (38)
- SENILE DEMENTIA OF LEWY BODY TYPE AND SPECTRUM OF LEWY BODY DISEASE (1989) (38)
- Association studies between risk for late‐onset Alzheimer's disease and variants in insulin degrading enzyme (2005) (38)
- Neuropathological correlates of volumetric MRI in autopsy-confirmed Lewy body dementia (2012) (37)
- Attenuation of Aβ deposition in the entorhinal cortex of normal elderly individuals associated with tobacco smoking (2005) (37)
- Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease (1985) (36)
- Neurochemistry of consciousness: cholinergic pathologies in the human brain. (2004) (36)
- Aluminosilicates and the ageing brain: implications for the pathogenesis of Alzheimer's disease. (1986) (36)
- Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases. (1987) (36)
- The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodies (2000) (36)
- Increased binding to 5-HT1A and 5-HT2A receptors is associated with large vessel infarction and relative preservation of cognition. (2009) (36)
- Increased neural progenitors in vascular dementia (2011) (35)
- Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases. (1998) (35)
- Dialysis encephalopathy syndrome (1976) (35)
- Blood acetyl- and butyrylcholinesterases in senile dementia of Alzheimer type (1985) (35)
- Apolipoprotein E and alpha‐1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies Distinctions between diseases (1998) (35)
- Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's diseases (1988) (35)
- Intraluminal colonic calcifications associated with anorectal atresia. Prenatal sonographic detection. (1990) (34)
- Lewy body dementia--clinical, pathological and neurochemical interconnections. (1997) (34)
- Inflammatory Mediators in the Frontal Lobe of Patients with Mixed and Vascular Dementia (2008) (34)
- Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele. (1997) (34)
- Co-Localization of Aluminium and Silicon in Senile Plaques: Implications for the Neurochemical Pathology of Alzheimer’s Disease (1985) (33)
- p53 protein expression in ductal carcinoma in situ (DCIS) of the breast (1997) (33)
- Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies (2006) (32)
- Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation. (2000) (32)
- A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodies. (2002) (31)
- Quantification of βA4 protein deposition in the medial temporal lobe: A comparison of Alzheimer's disease and senile dementia of the Lewy body type (1992) (31)
- Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer’s disease (2009) (31)
- Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems (2008) (31)
- Molecular Forms of Butyrylcholinesterase in the Human Neocortex During Development and Degeneration of the Cortical Cholinergic System (1987) (30)
- Autoradiographic comparison of cholinergic and other transmitter receptors in the normal human hippocampus (1993) (29)
- Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease (1992) (29)
- Mutation analysis of patients with neuronal intermediate filament inclusion disease (NIFID) (2006) (29)
- Neocortical concentrations of neuropeptides in senile dementia of the alzheimer and lewy body type: Comparison with parkinson's disease and severity correlations (1991) (28)
- Dementia with Lewy Bodies: What is the neuropathological basis of dementia associated with Lewy bodies? (1996) (28)
- Risk for Alzheimer's disease in older late-onset cases is associated with HLA-DRB1*03 (1999) (27)
- β‐Amyloidosis in Normal Aging and Transmitter Signaling in Human Temporal Lobe a (1996) (27)
- Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (Trisomy 21) (1994) (27)
- Role of ligamentum flavum in the symptomatology of prolapsed lumbar intervertebral discs. (1975) (27)
- Properties and possible significance of substance P and insulin fibrils (1981) (27)
- The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target (2018) (27)
- Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia. (1990) (27)
- FUS Immunogold Labeling TEM Analysis of the Neuronal Cytoplasmic Inclusions of Neuronal Intermediate Filament Inclusion Disease: A Frontotemporal Lobar Degeneration with FUS Proteinopathy (2011) (26)
- Glutamate receptor binding in the human hippocampus and adjacent cortex during development and aging (1996) (26)
- Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia. (2007) (26)
- Visual hallucinations and the cholinergic system in dementia. (1990) (26)
- Circadian variations in cholinergic enzymes and muscarinic receptor binding in human cerebral cortex (1977) (25)
- The K Variant of the Butyrylcholinesterase Gene Is Associated with Reduced Phosphorylation of Tau in Dementia Patients (2005) (24)
- A review of neuropathological and neurochemical correlates of Alzheimer's disease. (1985) (24)
- ApoE2 Allele, Down's Syndrome, and Dementia a (1996) (24)
- Autoradiographic comparison of the distribution of [3H]MK801 and [3H]CNQX in the human cerebellum during development and aging (1993) (24)
- Alpha2-macroglobulin polymorphisms in Alzheimer's disease and dementia with Lewy bodies. (1999) (24)
- New insights into the nature of senile (Alzheimer-type) plaques (1985) (24)
- Small vessel disease pathological changes in neurodegenerative and vascular dementias concomitant with autonomic dysfunction (2020) (24)
- Transmitters in the Developing and Senescent Human Brain (1993) (23)
- Recovery and measurement of RNA in Alzheimer's disease by molecular hybridisation. (1987) (23)
- A quantitative comparison of plaque types in Alzheimer’s disease and senile dementia of the Lewy body type (1996) (23)
- Use of post-mortem human synaptosomes for studies of metabolism and transmitter amino acid release (1982) (23)
- Age-associated decline in high-affinity nicotine binding in human brain frontal-cortex does not correlate with the changes in choline-acetyltransferase activity (1992) (23)
- The spectrum and severity of FUS-immunoreactive inclusions in the frontal and temporal lobes of ten cases of neuronal intermediate filament inclusion disease (2011) (23)
- Neurogenic marker abnormalities in the hippocampus in dementia with Lewy bodies (2011) (23)
- Non-Picks frontotemporal dementia imitating schizophrenia in a 22-year-old man (2003) (23)
- Distribution of nerve growth factor receptor immunoreactivity in the human hippocampus (1991) (22)
- Comparison of major cortical aminopeptidase activity in normal brain and brain from patients with Alzheimer's disease (1989) (21)
- Distribution of [3H]MK801 binding in the normal aged human hippocampus (1989) (21)
- Involvement of α6/α3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [125I]-α-conotoxin MII binding in the thalamus and striatum. (2004) (21)
- Influence of site of origin of lung carcinomas on clinical presentation and central nervous system metastases. (1979) (20)
- Abnormally Phosphorylated Tau Protein in Senile Dementia of Lewy Body Type and Alzheimer Disease: Evidence that the Disorders Are Distinct (1995) (20)
- Multiple chromosome rearrangements in a childhood ependymoma. (1988) (20)
- Transferrin and transferrin receptors in normal brain and in Alzheimer's disease (1987) (20)
- Raised Thyrotrophin‐Releasing Hormone, Pyroglutamylamino Peptidase, and Proline Endopeptidase Are Present in the Spinal Cord of Wobbler Mice but Not in Human Motor Neurone Disease (1987) (20)
- Partial loss of parvalbumin‐containing hippocampal interneurons in dementia with Lewy bodies (2011) (20)
- Examination of Parameters Influencing [3H]MK‐801 Binding in Postmortem Human Cortex (1992) (20)
- Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline (2007) (19)
- Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls. (1994) (19)
- Frequency of HLA-A and B alleles in early and late-onset Alzheimer's disease (1999) (19)
- Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD. (2000) (19)
- Dementia with Lewy Bodies: Altered consciousness and transmitter signalling in Lewy body dementia (1996) (19)
- The distribution pattern of pathology and cholinergic deficits in amygdaloid complex in Alzheimer's disease and dementia with Lewy bodies (2006) (18)
- The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system (2002) (18)
- APOE Genotype and Alzheimer´s Disease (2000) (18)
- What are the relations between Lewy body disease and AD? (1998) (18)
- Neurochemical pathology and therapeutic strategies in degenerative dementia (1993) (17)
- Neuroleptics are associated with more severe tangle pathology in dementia with Lewy bodies (2005) (17)
- Nodular fasciitis causing unilateral proptosis. (1975) (17)
- Mutation screening in exons 3 and 4 of α‐synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases (1998) (16)
- Expression of the alpha3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease. (1998) (16)
- No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer's disease (1997) (16)
- Hippocampal p75 nerve growth factor receptor immunoreactivity in development, normal aging and senescence. (1993) (16)
- Diagnosis of Creutzfeldt-Jakob disease by electron microscopy (1990) (15)
- New observations on the nature of senile plaque cores (1984) (15)
- The effect of non-competitive N-methyl-D-aspartate receptor antagonism on cerebral oedema and cerebral infarct size in the aging ischaemic brain. (1997) (15)
- HUMAN BRAIN TEMPERATURE AT NECROPSY: A GUIDE IN POST-MORTEM BIOCHEMISTRY (1977) (15)
- Dementia in old age: identification of a clinically and pathologically distinct disease category. (1990) (14)
- Multiple substrates of late-onset dementia: implications for brain protection. (2001) (14)
- Dopamine D2 receptors in demented patients with severe neuroleptic sensitivity. (1994) (14)
- Chromatographic characterization of neuropeptides in post mortem human brain (1984) (14)
- Report of GBM Metastasis to the Parotid Gland (2005) (14)
- Nicotinic ( 3 H nicotine) receptor binding in human brain: characterization and involvement in cholinergic neuropathology (1989) (13)
- Some Observations and Speculations Concerning the Cholinergic System and Neuropeptides in Alzheimer's Disease (1983) (13)
- Beta-amyloidosis in normal aging and transmitter signaling in human temporal lobe. (1996) (13)
- Carotid sinus hypersensitivity associated with focal α-synucleinopathy of the autonomic nervous system (2006) (13)
- Loss of Musashi1 in Lewy body dementia associated with cholinergic deficit (2007) (12)
- Lewy body diseases (2002) (12)
- Tautological tangles in neuropathologic criteria for dementias associated with Lewy bodies (1996) (12)
- Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease (1983) (12)
- [3H]Nitrendipine binding in temporal cortex in Alzheimer's and Huntington's diseases (1991) (11)
- Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients (2008) (11)
- Parkinson's disease, but not Alzheimer's disease, Lewy body variant associated with mutant alleles at cytochrome P450 gene (1994) (11)
- DIETARY LECITHIN SUPPLEMENTS IN DEMENTIA OF ALZHEIMER TYPE? (1977) (11)
- No association between a polymorphism in the presenilin 1 gene and dementia with Lewy bodies (1997) (11)
- Susceptibility‐weighted imaging changes suggesting brain iron accumulation in Huntington's disease: an epiphenomenon which causes diagnostic difficulty (2014) (10)
- Alzheimer's Disease and Parkinson's Disease: Pathological and Biochemical Changes Associated with Dementia (1985) (10)
- Evidence of a circadian fluctuation in neurotransmitter enzyme activities measured in autopsy human brain (1977) (10)
- The effect of age on cerebral oedema, cerebral infarction and neuroprotective potential in experimental occlusive stroke. (1994) (10)
- Clinical Diagnostic Criteria for Lewy Body Dementia (1992) (10)
- Neurotransmitter Correlates of Neuropsychiatric Symptoms in Dementia with Lewy Bodies (2003) (10)
- White matter pathology in Alzheimer's disease and vascular dementia: quantification by amyloid‐β precursor protein immunocytochemistry (2002) (9)
- LITHIUM PROPHYLAXIS INHIBITS CHOLINE TRANSPORT IN POST-MORTEM BRAIN (1986) (9)
- Sonographic and pathological features of callosal hypoplasia in non-ketotic hyperglycinaemia. (1990) (9)
- Respiratory Chain Dysfunction in Progressive Neuronal Degeneration of Childhood With Liver Disease (1996) (9)
- Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum. (2004) (8)
- Cholinergic Neuropathology and Nicotinic Receptor Binding in the Human Brain (1988) (8)
- A prospectively studied clinicopathological case of ‘vascular depression’ (2003) (8)
- Cytogenetic abnormalities in a disseminated medulloblastoma. (1993) (8)
- Thalamic D 2 receptors in dementia with Lewy bodies, Parkinson’s disease, and Parkinson’s disease dementia (2007) (8)
- Prognostic factors in medulloblastoma (1992) (8)
- Spatial patterns of FUS-immunoreactive neuronal cytoplasmic inclusions (NCI) in neuronal intermediate filament inclusion disease (NIFID) (2011) (8)
- Rapid cycling bipolar affective disorder and familial learning disability associated with temporal lobe (occipitotemporal gyrus) cortical dysplasia. (1995) (8)
- Distribution of neurofibrillary tangle formation and [3H]‐D‐aspartate receptor binding in the thalamus in the normal elderly brain, in Alzheimer's disease and in Parkinson's disease (1990) (7)
- Examination of Cholinergic and Neuropeptide Receptor Alterations in Senile Dementia of the Alzheimer’s Type (SDAT) (1986) (7)
- Brain Biochemistry in Dementia of Alzheimer‑type (1981) (6)
- Measurement of relative concentrations of rna in post mortem brains from senile dementia of the alzheimer type and controls (1985) (6)
- Psychotic symptoms in Alzheimer's disease (1992) (6)
- Neuropathological and Neurochemical Correlates of Alzheimer‑type and Parkinsonian Dementia (1984) (6)
- Neuropeptides in gliomas: identification of somatostatin 14 in a medulloblastoma. (1986) (6)
- A new dementia: Neurofilament inclusion body dementia (2002) (5)
- Neurotransmitter and neuropeptide systems in Alzheimer-type dementia. (1982) (5)
- UNUSUAL CARDIAC AND NEUROLOGICAL REACTIONS TO NARCOTICS (1973) (5)
- Elderly individuals with FTLD. (2013) (5)
- Structural and Chemical Aspects of Cortical Pathology in Alzheimer’s Disease (1986) (4)
- N-methyl-D-aspartate (NMDA) and non-NMDA binding sites in developing human frontal cortex (1993) (4)
- [abstract] Marked neuroleptic sensitivity in dementia with Lewy bodies and Parkinson's disease (2003) (4)
- Acetylcholinesterase in Alzheimer's Disease (1983) (4)
- Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's disease and Parkinson's disease cases (1999) (4)
- Dopamine metabolism in postmortem caudate-nucleus in neurodegenerative disorders (1994) (3)
- Dementia with Lewy bodies: no association of polymorphisms in the human synphilin gene (2004) (3)
- Clinical presentations in monozygotic twins with dementia with Lewy bodies. (2002) (3)
- Cholinergic and gaba systems in dementia and normal old-age (1977) (3)
- The serotonergic system Alzheimer's disease and normal neocortical post-mortem brain: neurochemical and clinical correlates (1993) (3)
- CIRCADIAN VARIATION IN HUMAN BRAIN ENZYMES (1977) (3)
- A Quantitative Study of Patterns of Basement Membrane in Ductal Carcinoma In Situ (DCIS) of the Breast (1995) (3)
- The Ageing Brain and its Pathology (1982) (3)
- Serum creatine kinase-BB levels and cerebral cortical creatine kinase activity in senile dementia of the Alzheimer type (1987) (3)
- Density, Distribution and Prevalence of Lewy Bodies in the Elderly - Influence of Neuropsychiatric Bias with Epidemiologic and Diagnostic Implication (1991) (3)
- Electron-microscopic demonstration of fibrillary forms of small peptides common to brain and gut (1981) (2)
- Nerve growth factor receptor-like immunoreactivity in the human spinal cord. (1992) (2)
- Neuropathology of Dementia (1984) (2)
- Dementia with Lewy Bodies: Introduction (1996) (2)
- A major peptidergic tract in the human brain — Relationship to stria terminalis and anterior commissure (1982) (2)
- The Nicotinic Cholinergic System and ß-Amyloidosis (1997) (2)
- Rate of cognitive decline in PD (2006) (2)
- Increased Alzheimer pathology in Parkinson's disease is associated with chronic antimuscarinic drug treatment (2002) (2)
- GASTRIN/CCK IMMUNOREACTIVITY IN HUMAN CEREBRAL CORTICAL GREY AND WHITE MATTER (1981) (1)
- Neuropathology of the cholinergic system in the human brain (1984) (1)
- Dementia with Lewy Bodies: Biographical note on F. H. Lewy (1996) (1)
- Tobacco use is associated with attenuation of beta-amyloidosis in hippocampus and entorhinal cortex of normal elderly individuals (2002) (1)
- Cortical tau-protein and neurofibrillary tangles in lewy body dementia, alzheimers-disease, parkinsons-disease and controls (1994) (1)
- Letter to the editor (1991) (1)
- Recovery and measurement of specific RNA species from postmortem brain tissue: a general reduction in Alzheimerʼs disease detected by molecular hybridization (1987) (1)
- On neuronal ill health (1994) (1)
- Unfolding the nature of senile plaque amyloid (1986) (1)
- Neurodegenerative Changes in Aging and Dementia: A Comparison of Alzheimer and Lewy Body Type Pathology (1992) (1)
- Laminar distribution of neurofilament inclusions and swollen achromatic neurons in neurofilament inclusion disease (NID) (2004) (1)
- THE HUMAN BRAINOME: HUMAN BRAIN GENOME, TRANSCRIPTOME, AND PROTEOME INTEGRATION (2016) (1)
- Neurotensin immunoreactivity and choline acetyltransferase activity in the cerebral cortex in Parkinson's disease (1983) (1)
- Cholinergic pathology in Lewy body dementia (2006) (1)
- Existence in vitro of fibrillary aggregates of substance P, cholecystokinin octapeptide, somatostatin and related molecules (1981) (1)
- Post-mortem investigation of neurochemical and neuro-peptidergic hypothesis of depression (1988) (1)
- Effects of substance P in the hippocampal slice preparation — Activity of substance P and substance P fibrillary polymers (1982) (1)
- Neurochemical Pathology of Alzheimer's Disease - The Cholinergic Concept (1984) (1)
- P.3.008 Dopaminergic and nicotinic interactions in the human striatum in dementia with lewy bodies, chronic schizophrenia and Parkinson's disease (1996) (1)
- Monoaminergic Function in Postmortem Brain in Depression (1982) (1)
- The status of hippocampal cholinergic receptors in human cognitive disorders (1986) (1)
- Transmitter Systems in Alzheimer's Disease (1983) (1)
- Cholinergic controversies. (1991) (1)
- D2 receptors in thalamus and cortex in Parkinson's disease dementia (PDD), Parkinson's disease (PD) and dementia with Lewy bodies (DLB) (2006) (1)
- Postmortem Investigation of Serotonergic and Peptidergic Hypotheses of Affective Illness (1989) (1)
- CCK immunoreactivity in human cerebral cortical grey and white matter in health and disease (1980) (0)
- Implications of Neuropathological and Neurochemical Abnormalities in Alzheimer's Disease (1984) (0)
- Alzheimer's and Parkinson's disease: anatomical, pathological and biochemical aspects (1986) (0)
- Case Studies in Dementia: Man with fluctuating confusion (2011) (0)
- APOE2-theupside of Down syndrome (1994) (0)
- CNS cholinergic markers and Alzheimer's disease (1986) (0)
- Characterisation of white matter pathology in vascular dementia and Alzheimer's disease (2002) (0)
- Hippocampal somatostatin receptors in human cognitive disorders (1986) (0)
- Dementia with Lewy Bodies: Foreword (1996) (0)
- MtDNA mutations in neurodegenerative disease (2007) (0)
- P1-322: Pathologic diagnosis of Alzheimer's disease contributes more to medial temporal lobe atrophy than measures of pathology in demented and nondemented subjects (2008) (0)
- Sonographic andpathological features ofcallosal hypoplasia innon-ketotic hyperglycinaemia (2011) (0)
- Changes in human brain nicotine receptors in dementia, development and aging: association with neuropathology and plasticity (1995) (0)
- Aluminosilicates and senile plaque formation in Alzheimerʼs disease (1987) (0)
- 640 Consensus criteria for the clinical diagnosis of dementia with Lewy bodies (DLB) (1996) (0)
- Comparison of clinical, FP-CIT spet imaging, and autopsy diagnosis of DLB (2006) (0)
- Dementia with Lewy Bodies: Group photograph (1996) (0)
- Dementia with Lewy Bodies: Guidelines for the selection of cortical areas for the evaluation of Lewy body distribution and proposed diagnostic rating protocol (1996) (0)
- P4-164 Molecular study of dementia with neurofilament inclusions (2004) (0)
- IC-P1-006: Pathologic diagnosis of Alzheimer's disease contributes more to medial temporal lobe atrophy than measures of pathology in demented and non-demented subjects (2008) (0)
- Experimental Occlusive Stroke in the Ageing Brain (1993) (0)
- Determination of the alpha-1 anti-chymotrypsin polymorphism in Alzheimer's disease (1996) (0)
- Immunotyping of cerebrospinal fluid lymphocytes by flow cytometry in primary central nervous system B-cell lymphoma (2005) (0)
- Factors influencing the formation and stability of substance P fibrillary polymers (1982) (0)
- Genetics of Alzheimer's disease (1982) (0)
- Baborie et al - Elderly Individuals with FTLD - Arch Neurol.2011.3323v1 (2015) (0)
- Analysis of ependymomas using comparative genomic hybridisation (2001) (0)
- Histochemistry of Brain Cholinesterases in Normal Old Age and Alzheimer's disease (1980) (0)
- 91 DEMENTIA WITH LEWY BODIES (2002) (0)
- Dementia with Lewy Bodies: Consensus criteria for the clinical diagnosis of dementia with Lewy bodies (DLB) (1996) (0)
- Expression of the ErbB-Neuregulin Signaling Network during Human Cerebellar Development : Implications for the Biology of Mceluilohiastonia 1 (2006) (0)
- The response of human nicotinic receptors in the hippocampus and cerebellum to cigarette smoking: Possible neuroprotective associates (1995) (0)
- Dementia with Lewy Bodies: Index (1996) (0)
- Loss of synaptic proteins and choline acetyltransferase in primary and secondary visual cortex in dementia with Lewy bodies (2008) (0)
- Altered tau processing: its role in development of dementia in Alzheimer's disease and Lewy body disease (1996) (0)
- THE MEDICAL PROFESSION IN GLASGOW. (1870) (0)
- The neuropathology of mitochondrial DNA disorders (2004) (0)
- Volume contents (1994) (0)
- Electrocardiogram and hard drugs. (1973) (0)
- From James Parkinson to Friederich Lewy: leaving landmarks for further research journeys. (2003) (0)
- Clinical, pathological and neurochemical characteristics of Lewy body dementia (1995) (0)
- Recovery and measurement of RNA in Alzheimerʼs disease by molecular hybridization (1988) (0)
- An autoradiographic approach for studying the distribution of neurotransmitter receptor binding sites on biopsy samples of human gliomas (1986) (0)
- Dementia with Lewy Bodies: Résumeacute; of pathological workshop sessions (1996) (0)
- Expression of p53, Waf-1, Bcl-2, and Bax in central primitive neuroectodermal tumours (cPNET) (1998) (0)
- Consensus criteria for the pathological evaluation of dementia with Lewy bodies (1996) (0)
- O4-06-01 α-Internexin is present in the hallmark lesions of neuronal intermediate filament inclusion disease (2004) (0)
- The Management of Psychotic Symptoms in Dementia with Lewy Bodies (dlb) (1996) (0)
- Comparison of clinical, fp-cit spet imaging and neuropathological diagnosis of DLB at autopsy (2007) (0)
- Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: Increased alpha 7 immunoreactivity of astrocytes in Alzheimer's disease (2002) (0)
- Factors associated with cognitive decline in Down syndrome (2000) (0)
- Management of Noncognitive Symptoms in Dementia with Lewy Bodies (1998) (0)
- Amyloid and Alzheimer's disease: A question of specificity (1989) (0)
- Genetic abnormalities detected in genomic hybridisation epenclymomas by comparative (2002) (0)
- Neuronal apoptosis occurs in patients with mitochondrial DNA disorders (2003) (0)
- Nerve growth factor receptor-positive fibre pathways in the human neocortex. (1990) (0)
- Decreased levels of amyloid beta peptide in the brains of smokers (2005) (0)
- Ubiquitinated Dot-Profiles (UDP) are decreased in the hippocampus in Alzheimer's disease compared with Lewy body dementia, Parkinson's disease, and controls R Raghavan, PG Ince, RH Perry. Neuropathology Department, Newcastle General Hospital, Newcastle upon Tyne NE4 6BE UK (1994) (0)
- Optimal brain banking: The Newcastle experience (1996) (0)
- Dementia with Lewy Bodies: Plate section (1996) (0)
- Medial temporal lobe volumes on MRI and neuropathology in autopsy-confirmed Lewy body dementia (2011) (0)
- Cholinergic and Monoaminergic Correlates of Clinical Symptoms in Dementia with Lewy Bodies (2002) (0)
- [meeting abstract] Decreased levels of amyloid-beta peptide in the entorhinal cortex of normal elderly individuals associated with tobacco smoking (2005) (0)
- Letter: Unusual cardiac and neurological reactions to narcotics. (1973) (0)
- [abstract] Neuropathological changes in late life depression (2003) (0)
- Nicotine inhibits the release of H3 GABA from rat and human cerebral cortex, in vitro (1990) (0)
- Medial temporal lobe volumes on MRI and neuropathology in autopsy confirmed Lewy body dementia (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Robert Henry Perry?
Robert Henry Perry is affiliated with the following schools:
